title: Epigenetic mechanisms in mood disorders: targeting neuroplasticity.
abstract: Developing novel therapeutics and diagnostic tools based upon an understanding of neuroplasticity is critical in order to improve the treatment and ultimately the prevention of a broad range of nervous system disorders. In the case of mood disorders, such as major depressive disorder (MDD) and bipolar disorder (BPD), where diagnoses are based solely on nosology rather than pathophysiology, there exists a clear unmet medical need to advance our understanding of the underlying molecular mechanisms and to develop fundamentally new mechanism experimental medicines with improved efficacy. In this context, recent preclinical molecular, cellular, and behavioral findings have begun to reveal the importance of epigenetic mechanisms that alter chromatin structure and dynamically regulate patterns of gene expression that may play a critical role in the pathophysiology of mood disorders. Here, we will review recent advances involving the use of animal models in combination with genetic and pharmacological probes to dissect the underlying molecular mechanisms and neurobiological consequence of targeting this chromatin-mediated neuroplasticity. We discuss evidence for the direct and indirect effects of mood stabilizers, antidepressants, and antipsychotics, among their many other effects, on chromatin-modifying enzymes and on the epigenetic state of defined genomic loci, in defined cell types and in specific regions of the brain. These data, as well as findings from patient-derived tissue, have also begun to reveal alterations of epigenetic mechanisms in the pathophysiology and treatment of mood disorders. We summarize growing evidence supporting the notion that selectively targeting chromatin-modifying complexes, including those containing histone deacetylases (HDACs), provides a means to reversibly alter the acetylation state of neuronal chromatin and beneficially impact neuronal activity-regulated gene transcription and mood-related behaviors. Looking beyond current knowledge, we discuss how high-resolution, whole-genome methodologies, such as RNA-sequencing (RNA-Seq) for transcriptome analysis and chromatin immunoprecipitation-sequencing (ChIP-Seq) for analyzing genome-wide occupancy of chromatin-associated factors, are beginning to provide an unprecedented view of both specific genomic loci as well as global properties of chromatin in the nervous system. These methodologies when applied to the characterization of model systems, including those of patient-derived induced pluripotent cell (iPSC) and induced neurons (iNs), will greatly shape our understanding of epigenetic mechanisms and the impact of genetic variation on the regulatory regions of the human genome that can affect neuroplasticity. Finally, we point out critical unanswered questions and areas where additional data are needed in order to better understand the potential to target mechanisms of chromatin-mediated neuroplasticity for novel treatments of mood and other psychiatric disorders.
authors: Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Reseach, 185 Cambridge Street, Boston, MA 02114, USA; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA.
authors: D M
authors: DM
authors: Fass
authors: Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Reseach, 185 Cambridge Street, Boston, MA 02114, USA; Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Department of Radiology, Harvard Medical School, 149, 13th Street, Charlestown, MA 02129, USA.
authors: F A
authors: FA
authors: Schroeder
authors: Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Research, 185 Cambridge Street, Boston, MA 02114, USA.
authors: R H
authors: RH
authors: Perlis
authors: Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Reseach, 185 Cambridge Street, Boston, MA 02114, USA; Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA; Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Center for Human Genetic Research, 185 Cambridge Street, Boston, MA 02114, USA. Electronic address: haggarty@chgr.mgh.harvard.edu.
authors: S J
authors: SJ
authors: Haggarty
mesh_terms: D000818:Animals; D042002:Chromatin Assembly and Disassembly; D004195:Disease Models, Animal; D044127:Epigenesis, Genetic; D006801:Humans; D051379:Mice; D019964:Mood Disorders / Q000235:genetics*; D009473:Neuronal Plasticity / Q000235:genetics*; D051381:Rats
keywords: chromatin; epigenetics; experimental medicine; mood disorders; neuroplasticity
references: Nat Rev Neurosci. 2005 Feb;6(2):108-18
references: 15654323
references: Dev Cell. 2012 Mar 13;22(3):477-87
references: 22421040
references: Neuron. 2011 Jun 9;70(5):813-29
references: 21658577
references: Nature. 2007 May 10;447(7141):178-82
references: 17468743
references: Neuron. 2011 Jan 27;69(2):359-72
references: 21262472
references: Harv Rev Psychiatry. 2010 Sep-Oct;18(5):293-303
references: 20825266
references: Mol Interv. 2003 Jun;3(4):220-9
references: 14993449
references: Arch Gen Psychiatry. 2002 Jun;59(6):530-7
references: 12044195
references: ACS Chem Neurosci. 2012 Feb 15;3(2):120-128
references: 22754608
references: Neuropharmacology. 2009 Jul;57(1):67-74
references: 19393671
references: Eur J Neurosci. 2008 May;27(10):2701-13
references: 18513320
references: ACS Med Chem Lett. 2010 Oct 8;2(1):39-42
references: 21874153
references: Stem Cells. 2011 Dec;29(12):1915-22
references: 22009633
references: Chem Biol. 2006 Jun;13(6):563-7
references: 16793513
references: Science. 2011 Jun 17;332(6036):1436-9
references: 21680841
references: Neuropharmacology. 2010 Mar-Apr;58(4-5):683-93
references: 20018197
references: Neuropsychopharmacology. 2013 Jan;38(1):124-37
references: 22692567
references: Cell. 2008 Jul 25;134(2):329-40
references: 18662547
references: Chem Soc Rev. 2008 Jul;37(7):1402-13
references: 18568166
references: World J Biol Psychiatry. 2012 Sep;13(6):458-67
references: 21812623
references: CNS Drugs. 2009 Aug;23(8):627-47
references: 19594193
references: Mol Pharmacol. 2009 Feb;75(2):342-54
references: 19029285
references: Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12578-83
references: 16113080
references: Neuron. 2004 Jun 24;42(6):947-59
references: 15207239
references: Nat Genet. 2011 Sep 18;43(10):977-83
references: 21926972
references: Neurosci Lett. 2008 Feb 13;432(1):54-7
references: 18164815
references: Trends Genet. 2003 May;19(5):286-93
references: 12711221
references: J Mol Biol. 2011 May 27;409(1):36-46
references: 21272588
references: Psychopharmacol Bull. 2001 Spring;35(2):5-49
references: 12397885
references: J Neurosci. 2010 Feb 17;30(7):2521-32
references: 20164337
references: Biochem J. 2003 Mar 15;370(Pt 3):737-49
references: 12429021
references: PLoS One. 2012;7(2):e30924
references: 22328923
references: PLoS One. 2012;7(9):e44498
references: 22973455
references: Arch Gen Psychiatry. 2001 Sep;58(9):844-50
references: 11545667
references: Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20912-7
references: 19934035
references: Nature. 2008 Oct 16;455(7215):894-902
references: 18923511
references: Cell. 2011 Apr 29;145(3):423-34
references: 21496894
references: Arch Gen Psychiatry. 2008 Aug;65(8):870-80
references: 18678792
references: Neurobiol Learn Mem. 2011 Jul;96(1):41-52
references: 21545841
references: Horm Behav. 2011 Mar;59(3):331-7
references: 20851702
references: Neuron. 2011 Aug 25;71(4):656-70
references: 21867882
references: Neuron. 2004 Jun 24;42(6):961-72
references: 15207240
references: Cell. 1997 May 16;89(4):641-53
references: 9160755
references: J Neurosci. 2009 Sep 16;29(37):11451-60
references: 19759294
references: PLoS One. 2011;6(9):e23356
references: 21915259
references: Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):840-53
references: 20833281
references: PLoS One. 2011;6(10):e26203
references: 22022567
references: Am J Psychiatry. 2006 Feb;163(2):217-24
references: 16449474
references: Nat Struct Mol Biol. 2010 Dec;17(12):1414-21
references: 21113167
references: PLoS Genet. 2011 Aug;7(8):e1002228
references: 21852959
references: Genome Res. 2012 Sep;22(9):1775-89
references: 22955988
references: Arch Gen Psychiatry. 2003 Mar;60(3):261-9
references: 12622659
references: J Physiol Paris. 2011 Dec;105(4-6):183-9
references: 21767641
references: Curr Opin Genet Dev. 2008 Apr;18(2):137-44
references: 18339542
references: Mol Cell. 2002 Jan;9(1):45-57
references: 11804585
references: Psychiatry Res. 2010 Apr 30;176(2-3):183-9
references: 20138370
references: Mol Psychiatry. 2013 Mar;18(3):340-6
references: 22212596
references: Science. 2009 Aug 14;325(5942):834-40
references: 19608861
references: Cell. 2002 Nov 15;111(4):483-93
references: 12437922
references: Science. 2011 Sep 30;333(6051):1881-5
references: 21960634
references: Postgrad Med. 2000 Apr;Spec No:1-104
references: 10895797
references: Dialogues Clin Neurosci. 2002 Mar;4(1):73-92
references: 22034240
references: Nat Rev Neurosci. 2007 May;8(5):355-67
references: 17453016
references: Epigenetics. 2011 May;6(5):548-51
references: 21527830
references: Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50
references: 11958165
references: Am J Psychiatry. 2000 Feb;157(2):220-8
references: 10671390
references: J Psychiatr Res. 2011 Aug;45(8):1106-12
references: 21349544
references: J Psychiatr Res. 2009 Jun;43(9):870-6
references: 19187942
references: Am J Psychiatry. 2001 Jun;158(6):906-12
references: 11384898
references: Science. 1994 Aug 19;265(5175):1104-7
references: 8066450
references: CNS Drugs. 2005;19 Suppl 1:1-93
references: 15998156
references: Schizophr Res. 2006 Dec;88(1-3):227-31
references: 16996718
references: J Biol Chem. 2004 Sep 24;279(39):40545-59
references: 15273246
references: Adv Pharmacol. 2006;54:95-117
references: 17175812
references: Bipolar Disord. 2012 Mar;14(2):146-50
references: 22420590
references: FEBS Lett. 2012 Aug 14;586(17):2692-704
references: 22710155
references: ChemMedChem. 2011 Sep 5;6(9):1593-602
references: 21732538
references: Neuropharmacology. 2013 Jan;64:81-96
references: 22771460
references: J Biol Chem. 2001 Sep 28;276(39):36734-41
references: 11473107
references: Arch Gen Psychiatry. 2007 Apr;64(4):442-55
references: 17404121
references: Biol Psychiatry. 2005 Mar 1;57(5):500-9
references: 15737665
references: Philos Trans R Soc Lond B Biol Sci. 2011 Aug 12;366(1575):2198-207
references: 21727125
references: Nat Commun. 2011 Oct 25;2:510
references: 22027590
references: Nat Rev Mol Cell Biol. 2007 Dec;8(12):983-94
references: 18037899
references: Annu Rev Biochem. 2012;81:145-66
references: 22663078
references: Cell Stem Cell. 2011 Dec 2;9(6):517-25
references: 22136927
references: Am J Psychiatry. 2003 Dec;160(12):2099-107
references: 14638578
references: J Biol Rhythms. 2011 Dec;26(6):541-51
references: 22215612
references: J Clin Psychiatry. 2008 May;69(5):769-82
references: 18452345
references: Curr Psychiatry Rep. 2012 Dec;14(6):643-9
references: 22996298
references: J Am Chem Soc. 2010 Dec 1;132(47):16962-76
references: 21067169
references: Biochem J. 2012 Nov 15;448(1):93-102
references: 22880885
references: J Neurosci. 2007 Jun 6;27(23):6128-40
references: 17553985
references: Mol Psychiatry. 2012 Dec;17(12):1261-71
references: 22230884
references: Psychiatr Q. 2000 Winter;71(4):309-29
references: 11025910
references: Nature. 2009 May 7;459(7243):55-60
references: 19424149
references: Cell. 2006 May 5;125(3):497-508
references: 16678094
references: Nat Neurosci. 2004 Aug;7(8):847-54
references: 15220929
references: J Neurosci. 2009 Jun 17;29(24):7820-32
references: 19535594
references: Nature. 2012 Feb 29;483(7388):222-6
references: 22388814
references: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):628-32
references: 17258370
references: Neuropharmacology. 2011 Jun;60(7-8):1007-16
references: 21074545
references: Neuropsychopharmacology. 2008 Jan;33(1):88-109
references: 17851537
references: Learn Mem. 2005 Mar-Apr;12(2):111-9
references: 15805310
references: Science. 1998 Jun 5;280(5369):1564-9
references: 9616112
references: Neuron. 2008 Dec 10;60(5):818-31
references: 19081377
references: J Neurosci. 2011 Jan 12;31(2):764-74
references: 21228185
references: Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17095-100
references: 12481028
references: Mol Psychiatry. 2007 Apr;12(4):385-97
references: 17264840
references: Science. 2010 Aug 6;329(5992):689-93
references: 20616235
references: Nat Chem Biol. 2010 Mar;6(3):238-243
references: 20139990
references: J Neurogenet. 2011 Oct;25(3):88-103
references: 21797804
references: Bipolar Disord. 2007 Jun;9(4):413-25
references: 17547587
references: J Clin Psychiatry. 2009 Feb;70(2):185-95
references: 19192454
references: Annu Rev Neurosci. 2011;34:389-412
references: 21692661
references: Behav Pharmacol. 2012 Aug;23(4):392-6
references: 22743604
references: J Neurosci. 2004 Jun 16;24(24):5603-10
references: 15201333
references: Neuron. 2008 Dec 26;60(6):961-74
references: 19109904
references: Nat Protoc. 2010 Mar;5(3):561-73
references: 20203671
references: Front Psychiatry. 2012 Mar 23;3:24
references: 22470355
references: Nat Neurosci. 2006 Apr;9(4):519-25
references: 16501568
references: Bipolar Disord. 2008 Mar;10(2):323-33
references: 18271912
references: Mol Neurobiol. 2011 Jun;43(3):207-14
references: 21424678
references: J Psychiatr Res. 2011 Oct;45(10):1295-300
references: 21592522
references: Nat Neurosci. 2012 Sep;15(9):1245-54
references: 22864611
references: J Neurosci. 2012 Mar 28;32(13):4400-16
references: 22457490
references: N Engl J Med. 2007 Apr 26;356(17):1711-22
references: 17392295
references: Nat Rev Drug Discov. 2011 Nov 11;10(12):915-29
references: 22076509
references: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6406-11
references: 17379666
references: Cell. 2005 May 6;121(3):425-36
references: 15882624
references: CNS Neurosci Ther. 2012 Mar;18(3):243-9
references: 22070541
references: J Psychiatr Res. 2010 Apr;44(5):263-70
references: 19767015
references: J Clin Psychiatry. 1993 Nov;54(11):405-18
references: 8270583
references: Biol Psychiatry. 2007 Jul 1;62(1):55-64
references: 16945350
references: Nature. 2007 Dec 13;450(7172):1086-90
references: 18075593
references: Nature. 1965 Sep 11;207(5002):1163-6
references: 5882364
references: Nat Rev Neurosci. 2006 Feb;7(2):137-51
references: 16429123
references: Curr Opin Struct Biol. 2008 Dec;18(6):682-9
references: 19056256
references: J Biol Chem. 2006 Jul 28;281(30):21209-21215
references: 16717091
references: J Clin Psychopharmacol. 2006 Dec;26(6):600-9
references: 17110817
references: Neuropsychopharmacology. 2013 Jan;38(1):183-97
references: 22643929